The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study

The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study

Author da Silva, Fernanda Borges Google Scholar
de Figueiredo-Pontes, Lorena Lobo Google Scholar
Ayrosa Madeira, Maria Isabel Google Scholar
de Araujo Koury, Luisa Correa Google Scholar
Gouvea de Lima, Ana Silvia Google Scholar
Scheucher, Priscila Santos Google Scholar
Coelho-Silva, Juan Luiz Google Scholar
Barbosa Pagnano, Katia Borgia Google Scholar
Pallota, Ronald Google Scholar
Chauffaille, Maria de Lourdes Autor UNIFESP Google Scholar
Pedron Oltramari, Marcos Roberto Google Scholar
Bittencourt, Rosane Isabel Google Scholar
Higashi, Marcia Google Scholar
Bendlin, Rodrigo Miguel Google Scholar
Rodrigues Pereira Velloso, Elvira Deolinda Google Scholar
Lowenberg, Bob Google Scholar
Ganser, Arnold Google Scholar
Berliner, Nancy Google Scholar
Valk, Peter Google Scholar
Rego, Eduardo Magalhaes Google Scholar
Traina, Fabiola Google Scholar
xmlui.dri2xhtml.METS-1.0.item-coverage Washington
Language English
Date 2017
Published in Blood Advances. Washington, v. 1, p. 86-89, 2017.
ISSN 2473-9529 (Sherpa/Romeo, impact factor)
Publisher Amer Soc Hematology
Extent 86-89
Origin http://dx.doi.org/10.1182/bloodadvances.2017GS102419
Access rights Closed access
Type Article
Web of Science ID WOS:000417682100028
URI https://repositorio.unifesp.br/handle/11600/54004

Show full item record




File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search


Browse

Statistics

My Account